Allogene Therapeutics to Report Second Quarter 2020 Financial Results on August 5, 2020
SOUTH SAN FRANCISCO, Calif., July 28, 2020 (GLOBE NEWSWIRE) -- Allogene Therapeutics, Inc. (Nasdaq: ALLO), a clinical-stage biotechnology company pioneering the development of allogeneic CAR T (AlloCAR T™) therapies for cancer, today announced that it will report second quarter 2020 financial results on Wednesday, August 5, 2020, prior to the open of the market. The announcement will be followed by a live audio webcast and conference call at 5:30 AM Pacific Time/8:30 AM Eastern Time.
About Allogene Therapeutics
Cautionary Note on Forward-Looking Statements
AlloCAR T™ is a trademark of Allogene Therapeutics, Inc.
Allogene Media/Investor Contact:
IoT Evolution #TECHSUPERSHOW Expo Hall Open
Autonomation and Predictability in IIoT